a b s t r a c t N-methyl-D-aspartate (NMDA) receptors assembled from GluN1 and GluN3 subunits are unique in that they form glycine-gated excitatory channels that are insensitive to glutamate and NMDA. Alternative splicing of the GluN1 subunit mRNA results in eight variants with regulated expression patterns and post-translational modifications. Here we investigate the role of residues in the GluN1 C-terminal alternatively spliced cassettes in receptor gating and modulation. We measured whole-cell currents from recombinant GluN1/GluN3A receptors expressed in HEK293 cells that differed in the sequence of their GluN1 C-terminal tail. We found that these residues controlled the level of steady-state activity and the degree to which activity was facilitated by zinc and protons. Further, we found that the phosphorylation status of sites specific to certain variants can also modulate channel activity. Based on these results we suggest that GluN1 C-terminal domain splicing may confer cell-specific and activity-dependent regulation onto the level and pharmacologic sensitivity of GluN1/GluN3A currents.
Introduction
GluN1 and GluN3 are homologous subunits in the N-methyl-Daspartate (NMDA) receptor family of tetrameric ionotropic glutamate receptors (iGluRs) . In contrast to all other iGluR subunits, they are insensitive to glutamate and instead bind glycine with high affinity. They can combine to form excitatory glycine-gated channels that are insensitive to the neurotransmitter glutamate, and are insensitive to the eponymous agonist NMDA (Chatterton et al., 2002) . The GluN3 subunit participates in fundamental physiological and pathological processes (Gallinat et al., 2007; Henson et al., 2012; Roberts et al., 2009; Tong et al., 2008; Das et al., 1998; Mueller and Meador-Woodruff, 2004; Zhou et al., 2009; Fernandes et al., 2014; Yuan et al., 2013; Pilli and Kumar, 2012; Mohamad et al., 2013; Marco et al., 2013; Larsen et al., 2011; Micu et al., 2006) . However, the literature on the biophysical and pharmacologic properties of GluN3-containing NMDA receptors remains sparse (Chatterton et al., 2002; Cummings and Popescu, 2016; Madry et al., 2008 Madry et al., , 2010 Madry et al., , 2007 Balasuriya et al., 2014; Wada et al., 2006; Woodward, 2007, 2009 ).
Functional NMDA receptors are obligate heterotetramers composed of two GluN1 and two GluN2(A-D) or/and GluN3(A, B) subunits. The GluN1 subunit is expressed ubiquitously in the central nervous system (CNS) whereas the GluN2/3 subunits have celltype and development-specific expression patterns (Traynelis et al., 2010) . Recombinant receptors expressed in heterologous cells showed that molecularly defined NMDA receptor isoforms have distinctive functional properties (Tong et al., 2008; Vicini et al., 1998) ; therefore, regulated subunit expression represents a major mechanism for adjusting the amplitude and time course of NMDA receptor responses during development, following activitydependent synaptic plasticity, and in certain acute and chronic disorders (Mueller and Meador-Woodruff, 2004; Fernandes et al., 2014; Yuan et al., 2013; Marco et al., 2013; Monyer et al., 1994; Wong et al., 2002; Fukaya et al., 2005) .
The molecular composition of native NMDA receptors is still unclear, and ascertaining the complement of NMDA receptor isoforms in a native preparation remains challenging for two main reasons. First, several subunits have substantial temporal and regional expression overlap (Monyer et al., 1994; Wong et al., 2002; Laurie et al., 1995; Laurie and Seeburg, 1994) , such that although identifying the protein subunits expressed limits the possible receptor combinations substantially, this approach by itself does not determine definitively which combinations generate the observed electrical signal. Second, the activation mechanisms and thus functional signatures of NMDA receptors have been delineated in sufficient detail for only a handful of molecularly defined receptors, with the best studied being the diheteromeric glutamatergic GluN1-1a/GluN2A and GluN1-1a/GluN2B receptors (Amico-Ruvio and Popescu, 2010; Auerbach and Zhou, 2005; Banke and Traynelis, 2003; Cummings and Popescu; Popescu and Auerbach, 2003; Popescu et al., 2004; Erreger et al., 2005) . Here we describe functional properties for four diheteromeric glycinergic GluN1/ GluN3A receptors.
GluN1 is ubiquitous across brain regions, is essential for the assembly of functional NMDA receptor channels, and controls their correct cellular localization (Laurie et al., 1995; Laurie and Seeburg, 1994; Okabe et al., 1999; Ehlers et al., 1995) . It occurs naturally as eight variants produced by alternative splicing of the GluN1 RNA (Zukin and Bennett, 1995; Hollmann et al., 1993) . Two types, denoted a and b, differ in their extracellular N-terminal sequences; and for each, four variants, denoted 1e4, differ in their intracellular C-terminal domain (CTD). GluN1 splicing changes developmentally and regionally; following neuronal activity; and in several neurological disorders Ehlers, 2003; Lau and Zukin, 2007; Vrajova et al., 2010; Law and Deakin, 2001; Prybylowski et al., 2001; Winkler et al., 1999) . GluN3A expression surges visibly shortly after birth (Wong et al., 2002) , when GluN1-1 is prominent in striatum, hippocampus, cortex, olfactory bulb, and dorsal septum; GluN1-2 is prominent throughout the forebrain; GluN1-3 is restricted to cortex, thalamus, and hippocampus; and GluN1-4 is observed in thalamus, colliculi, ventral septum, brainstem, and the CA3 region of the hippocampus . Despite this clear differential expression, the functional relevance of GluN1 splicing remains unclear. Here we delineate functional properties for four naturally occurring GluN1-a/GluN3A receptors.
Materials and methods

Molecular biology
We used plasmids encoding rat GluN1-1a (GenBank: U08261) (R. Wenthold, National Institutes of Health, Bethesda, MD), GluN1-2a (Genbank: U08262) and GluN1-3a (GenBank: U08265) (J. Woodward, Medical University of South Carolina), GluN1-4a (GenBank: U08267) (R.S. Zukin, Albert Einstein College of Medicine, Yeshiva University) and GluN3A (GenBank: NM_138546) (S. Lipton, University of California, San Diego). We sub-cloned, amplified, and sequenced the cDNA inserts as detailed elsewhere (Borschel et al., 2015) . We introduced residue-specific substitutions using the QuikChange site-directed mutagenesis kit (Stratagene, Amsterdam, Netherlands) and verified these by full-insert sequencing. GluN1, GluN3A, and GFP plasmids, in a 1:2:1 ratio, were transiently transfect into human embryonic kidney (HEK) 293 cells (ATCC CRL-1573; passages 25e35) using the calcium phosphate precipitation method (Chen and Okayama, 1987) . We incubated cells for 3 h with the transfection mixture, washed, and incubated for 12e24 h in DMEM supplemented with 2 mM MgCl 2 and 100 mM D-serine before using them for experiments.
Western blotting
Cell lysates were prepared from HEK293 cells transfected with the indicated plasmids. We used a plasma membrane protein extraction kit (Abcam) to isolate proteins expressed at the cell surface; we quantified extracted proteins with the bicinchoninic acid (BCA) protein assay (Pierce Biotechnology), and resolved mixtures on a 10% reducing sodium dodecylsulfate polyacrylamine gel, for~3 h at 100 V before transferring to a polyvinylidene difluoride (PVDF) membrane. We blocked membranes with 5% BSA (w/v) in TBS/Tween-20 buffer and probed them with mouse anticalnexin (1:5000) at room temperature for 1.5 h or rabbit anti-GFP (1:1000) and mouse anti-pan-GluN1 (1:1000) (Millipore) primary antibody in TBS/Tween-20 at 4 C overnight. We revealed specific bands by incubating with appropriate secondary antibody (goat anti-mouse or goat anti-rabbit) conjugated to horseradish peroxidase 1 h at room temperature, followed by ECL reagent (Pierce Biotechnology) to activate horseradish peroxidase before being exposed for 5e30 s to X-ray film. Following X-ray exposure, we stained the PVDF membrane with amido black to verify equal protein loading across lanes (Aldridge et al., 2008) , and performed densitometry analysis in ImageJ (National Institutes of Health).
Immunocytochemistry
Cells transfected with indicated subunits were plated on coverslips; grown for 1 day, and live-stained with wheat germ agglutinin conjugated to Alexafluor 647 (1:350) for 10 min at 4 C. Stained cells were fixed with 4% paraformaldehyde at 25 C for 15 min; permeabilized with 0.1% Tween in phosphate-buffered saline (PBS) for 10 min at 25 C; and treated with blocking buffer (2% BSA, 20% FBS, 0.01% sodium azide in PBS) for 1 h at 25 C. We probed blots with mouse anti-pan-GluN1 (1:1000) at 4 C overnight in a humid chamber, washed with PBS, and incubated with secondary antibody (donkey anti-mouse conjugated to Alexafluor 488; 1:500) at room temperature for 1 h. Following incubation with secondary antibody, cells were washed with PBS, incubated with DAPI for 5 min at room temperature, washed, and mounted on slides with Vectashied (Vector Labs, Burlingame, CA). Controls in which the primary antibody was omitted were stained with secondary antibodies in parallel with experimental samples. All antibodies were from Millipore (Darmstadt, Germany). We used an inverted Zeiss Axio Observer fluorescence microscope for imaging of coverslips and ImageJ for analyses (National Institutes of Health).
Whole-cell currents
Fire-polished electrodes (3e10 MU) were filled with intracellular solution containing (in mM): 135 CsCl, 22 CsOH, 2 MgCl 2 , 1 CaCl 2 , 11 EGTA, and 10 HEPES adjusted to pH 7.4. Cells were clamped at À70 mV and perfused with extracellular solutions containing (in mM): 150 NaCl, 2.5 KCl, 0.5 CaCl 2 , and 10 PIPES adjusted to pH 6.8 without (wash) or with 0.5 mM glycine. For calcium block experiments, 1.8 mM free Ca 2þ was achieved by buffering with 1.5 mM EGTA (MaxChelator, Stanford University). Solution applications were controlled through a lightly pressurized pinch valve system (BPS-8, ALA Scientific Instruments Inc., Westbury, NY). For each cell, 3e10 traces were averaged and analyzed in Clampfit. Currents were low-pass filtered at 2 kHz and digitally sampled at 5 kHz (Digidata 1440A, Molecular Devices, Sunnyvale, CA) using Clampex. The extent of desensitization was evaluated by calculating the I ss /I pk ratio. The time constant of current desensitization (t D ) was calculated by fitting the relaxation phase of the current, between peak (I pk ) and steady-state (I ss ) levels with a bi-exponential decay function.
Statistical analyses
We report results as rounded means ± standard error. We compared these values with one-way ANOVA and Bonferroni posthoc test in Graphpad Prism software and considered statistical differences significant for P < 0.05. Notations in figures indicate: *, P < 0.05; **, P < 0.01; and ***, P < 0.001.
Results
Expression of GluN1/GluN3A receptors in HEK293 cells
We co-expressed GluN3A with each of the four naturally occurring GluN1-a variants (1 through 4) in HEK293 cells (Fig. 1A) . We recorded maximal whole-cell excitatory glycinergic currents using 0.5 mM glycine, in external solutions containing 150 mM NaCl, 2.5 mM KCl, 0.5 mM CaCl 2 , and 10 mM PIPES, adjusted at pH 6.8 (Cummings and Popescu, 2016) . To compare functional expression across cells, we normalized the observed peak current amplitudes (I pk ) to the measured whole-cell capacitance, and calculated the current density in each condition. We found that relative to cells transfected with GluN1-1 or GluN1-2 variants, those transfected with GluN1-3 and GluN1-4 had current densities that were up to~4-fold larger; densities were lowest with GluN1-1/ GluN3A (14 ± 4 pA/pF, n ¼ 5) and highest for GluN1-4/GluN3A (57 ± 12 pA/pF, n ¼ 8) (F 3,19 ¼ 3.32, P ¼ 0.04) (Fig. 1B ). These results are in agreement with the range of values reported previously (Smothers and Woodward, 2009) .
Next, we examined whether this pattern of observed current correlated with the levels of GluN1 protein present in the wholecell lysate and at the plasma membrane. We measured GluN1 protein levels in total cell lysates and in isolated plasma membrane proteins by performing densitometry on Western blots probed with a pan anti-GluN1 antibody. We found that, in whole-cell lysates, GluN1-1, À2, and À3 occurred at similar levels, whereas GluN1-4 was substantially more prominent (F 3,8 ¼ 10.62, P ¼ 0.004) (Fig. 1C ), consistent with the higher level of current measured in cells co-transfected with GluN1-4 and GluN3A. Similarly, when probing plasma membrane proteins, we found lowest levels of GluN1-1 (2.1 ± 0.6, n ¼ 3), followed by GluN1-2 and GluN1-3 (4.0 ± 0.9, n ¼ 3; and 4.6 ± 0.9, n ¼ 3); and highest levels for GluN1-4 (13.2 ± 1.6, n ¼ 3) (F 3,8 ¼ 21.44, P ¼ 0.0004). Fluorescence imaging of immunostained cells (Fig. 1D) were consistent with these measured differences in the abundance of GluN1 variants at the plasma membrane, with GluN1-1 appearing to be least abundant, GluN1-2 and GluN1-3 having intermediate levels, and GluN1-4 most abundant.
Together, these results indicate that in HEK293 cells transfected with GluN1 and GluN3A, the magnitude of the recorded whole-cell glycinergic current varies with the C-terminal tail of GluN1. These differences in current amplitude can be attributed at least in part to differences in protein expression, and/or in trafficking to the plasma membrane, with GluN1-4/GluN3A channels likely being~5-fold more abundant than GluN1-1/GluN3A channels in the membrane (P < 0.001). We next examined whether these receptors also exhibit differences in biophysical properties such as kinetics and permeability.
Kinetic properties of GluN1/GluN3 currents
To delineate kinetic properties of the macroscopic currents, we elicited whole-cell responses from cells expressing individual GluN1-a variants and GluN3A using prolonged (5 s) applications of glycine (0.5 mM) at pH 6.8. We found previously that this acidic external medium strongly facilitates GluN1/GluN3A activity, regardless of the differential splicing in the extracellular N-terminal domain (a vs. b variants) (Cummings and Popescu, 2016) . Therefore, here we evaluated and compared receptors containing GluN1-a subunits that differed in their intracellular C-terminal sequence (1e4). All four channels examined produced deeply desensitizing currents, such that the steady-state current levels (I ss ) represented less than 10% of the initial peak levels (I pk ). For all receptors, the decay phase of the current was best described with biphasic exponential functions, whose weighted time constants were similar (t D ,~0.2e0.4 s) (F (3,25) ¼ 1.58, P ¼ 0.22). However, receptors containing the GluN1-2 or GluN1-3 subunit desensitized to a lesser extent (I ss /I pk , 0.08 ± 0.01, n ¼ 5; and 0.07 ± 0.01, n ¼ 11) than those containing GluN1-1a (0.03 ± 0.01, n ¼ 8) or GluN1-4 (0.02 ± 0.01, n ¼ 7) (F 3,27 ¼ 7.26, P ¼ 0.001) ( Fig. 2A and Table 1 ).
Permeation properties of GluN1/GluN3A channels
GluN1 CTD contains PKA phosphorylation sites that, in glutamatergic GluN1/GluN2 receptors, control the receptor's calcium permeability (Aman et al., 2014) . To examine whether the C-terminal sequence of GluN1 subunits influences conductance and permeation properties for glycinergic GluN1/GluN3A receptors, we recorded whole-cell currents in response to glycine (0.5 mM) in the absence or presence of 1.8 mM free external Ca 2þ and varied the applied pipette potential between À80 mV and þ60 mV in 20 mV increments. From these data, we calculated the voltage dependency of macroscopic currents and the extent of voltage-dependent Ca 2þ block.
The current reversal potential was~-6 mV for each of the four isoforms tested, and the I/V slope, measured at voltages more positive than À20 mV, showed similar chord conductance in the 25e30 pS range, similar to calculations of unitary conductance (~38 pS) and reversal potential (~5e10 mV) in previous studies (Chatterton et al., 2002; Madry et al., 2010) . Further, we found that, as expected for channels sensitive to voltage-dependent calciumblock, when Ca 2þ (1.8 mM free Ca 2þ ) was present extracellularly, the I/V relationship deviated from linearity in the negative range of voltages (Fig. 2B) . We expressed the degree of Ca 2þ block as a rectification index (I þ40 /I -60 ) and found this to be~4 for all variants. (pA) 8 ± 4 1 4 ± 4 5 9 ± 39 8 ± 3 I ss /I pk 0.03 ± 0.01 0.08 ± 0.01 These results indicate similar permeation properties for the four GluN1-a/GluN3A variants tested. Together, these results indicate that the C-terminus of the GluN1 subunits affects the kinetics of the whole-cell GluN1/GluN3A receptor responses by modulating the extent of desensitization, but has no discernible effects on permeation properties such as conductance, reversal potential, and voltage-dependent Ca 2þ block.
Pharmacological modulation of GluN1/GluN3A currents
Protons and zinc are endogenous ions that robustly potentiate GluN1/GluN3A currents (Cummings and Popescu, 2016; Madry et al., 2008) . Given the likely physiological importance of this pharmacologic regulation, we asked the GluN1 CTD sequence affects receptor responses to these ions.
Protons and zinc strongly reduce the activation of glutamatergic GluN1/GluN2 receptors and this inhibition is mediated by residues in the N-terminal domain of GluN1 and GluN2 subunits respectively (Traynelis et al., 1995; Paoletti et al., 1997) . In contrast, the strong facilitation of glycinergic GluN1/GluN3 current by protons and zinc depends on non-overlapping residues in the agonistbinding domain (Cummings and Popescu, 2016; Madry et al., 2008) . Specifically, we reported that proton-dependent facilitation is independent of N-terminal domains (Cummings and Popescu, 2016) . We also recorded glycinergic currents from receptors containing GluN1-1a or GluN1-1b and found that they were similarly potentiated by free zinc (50 mM) (I Zn /I ctr ¼ 12 ± 5-fold, and 9.2 ± 1.5-fold, respectively; P ¼ 0.6, unpaired Student's t-test). Therefore, zinc-dependent potentiation is not sensitive to splicing in the N-terminal domain of GluN1 subunits. Next, we describe experiments that ask whether C-terminal sequences alter the proton-and zinc-dependent effects.
We elicited whole-cell currents with glycine in physiologic proton concentrations (10 mM, pH 7.4); after the currents equilibrated to a steady-state level (I 7.4 ), we exposed cells to slightly acidic solution (pH 6.8) until the surge produced by acidification subsided and the current equilibrated to a new steady state-level (I 6.8 ) (Fig. 3A and Table 1) . With this protocol, we found that protons strongly potentiated steady-state currents from receptors containing GluN1-1 (12 ± 5-fold, n ¼ 4) or GluN1-4 (20 ± 9-fold, n ¼ 4); and to a lesser extent those from receptors containing GluN1-2 (2 ± 0.2-fold, n ¼ 5) or GluN1-3 (4 ± 0.9-fold, n ¼ 5) (F 3,14 ¼ 3.51, P ¼ 0.04). Next, we evaluated the extent of current potentiation by zinc. We recorded glycinergic whole-cell currents (0.5 mM, pH 7.4) in the absence or presence of 50 mM free zinc (Fig. 3B and Table 1 ). We found greatest potentiation for GluN1-2 (~16-fold) and smallest, although still substantial for GluN1-4 (~7-fold) (F 3,15 ¼ 3.74, P ¼ 0.04).
These results demonstrate that the degree of potentiation by allosteric ligands (protons and zinc) depends on the identity of the GluN1 CTD, whose sequence is controlled by differential splicing. Ionotropic glutamate receptors are targets of in situ phosphorylation by specific signaling cascades and this is an important mechanism of regulating their activity and lifetime in the membrane. Next, we investigated phosphorylation as a possible mechanism by which differences in the GluN1 CTD sequence may affect the kinetics and allosteric properties of GluN1/GluN3A receptors.
Effects of phosphorylation on GluN1/GluN3A currents
PKA phosphorylates GluN1-1a at S897 and PKC phosphorylates S890 and S896, in neurons in vivo (Tingley et al., 1997; Leonard and Hell, 1997) . Given that these residues are located on the C1 cassette, which may or may not be spliced out, we investigated whether dynamic phosphorylation at these sites can confer distinct functional properties onto GluN1/GluN3A receptors, as a possible means of splice variant-specific regulation.
To examine potential effects of phosphorylation at these sites, we introduced triple substitutions in GluN1a-3 at S890, S896, and Representative glycinergic whole-cell currents were recorded at pH 7.4 and pH 6.8 as indicated; inset, summary of proton-dependent increase in steady-state current (I 6.8 /I 7.4 ) (means ± SEM). (B) Representative glycinergic whole-cell currents recorded from the same cell in the absence (black, I ctr ) or continuous presence of 50 mM zinc (Gray, I Zn ), are shown superimposed and normalized to the zero-zinc GluN1-1/GluN3A current; inset, summary of zinc-dependent increase in peak current (I zn /I ctr ) (means ± SEM); *, P < 0.05, **, P < 0.01, ***, P < 0.001. S897, to mimic receptor states that are constitutively dephosphorylated (3S/3A) or phosphorylated (3S/3D). We co-expressed each mutant with GluN3A and recorded glycinergic whole-cell currents (0.5 mM, 5 s, pH 6.8). We found that relative to WT receptors (0.07 ± 0.01, n ¼ 11) (F 2,19 ¼ 5.92, P ¼ 0.01), the 3S/3A phosphodeficient mutant desensitized much less (I ss / I pk ¼ 0.16 ± 0.04, n ¼ 4, P < 0.01) while the 3S/3D phosphomimic mutant was not different (0.06 ± 0.02, n ¼ 7, P > 0.05). We observed no measurable differences in the desensitization time constant (3S/ 3D, t D ¼ 0.20 ± 0.06 s, n ¼ 7, P > 0.05; 3S/3A, t D ¼ 0.24 ± 0.04 s, n ¼ 4, P > 0.05) compared to WT (0.34 ± 0.03 s, n ¼ 11) (F 2,19 ¼ 3.38, P ¼ 0.06) (Fig. 4B and Table 2 ). These results indicate that the phosphorylation state of these sites can control the amplitude of the steady-state GluN1-a/GluN3A current. Therefore, these findings reveal yet another distinctive property of glycinergic NMDA receptors. For all glutamatergic NMDA receptors investigated so far phosphorylation elevates current levels; in contrast, our result indicate that phosphorylation attenuates glycinergic currents. This observation is notable because it may indicate a general pattern where modulatory actions of signaling pathways, by diffusible allosteric modulators or metabolic cues, exert opposing actions on glutamatergic and glycinergic excitatory currents (Cummings and Popescu, 2016; Madry et al., 2008; Paoletti et al., 1997; Traynelis and Cull-Candy, 1990; Chen and Roche, 2007) .
As expected from the observed lack of effect of GluN1-a splicing on permeation properties of GluN1/GluN3A receptors, we found that all four mutants had similar current -voltage relationships in the presence of 1.8 mM external calcium (I þ40 /I -60 ,~4e5) (Fig. 4C) .
Each GluN1 phosphorylation site makes unique contributions to GluN1/GluN2 receptor clustering and expression and are targets to independent signaling pathways (Tingley et al., 1997) . Therefore, we sought to determine which residue(s) mediated the increased activity we observed for the triple phosphorylation resistant mutants. We recorded glycine-elicited whole-cell responses and measured I ss /I pk ratios for receptors containing GluN1-3a subunits with the following single residue substitutions: S890A, S896A, and S897A (Fig. 4D ). Compared to WT receptors (0.07 ± 0.01, n ¼ 11) (F (3,31) ¼ 3.02, P ¼ 0.04), we observed a 2-fold increase in I ss /I pk for S896A-containing receptors (0.13 ± 0.03, n ¼ 6, P < 0.05), and no measurable differences for either receptors carrying either the S890A (0.05 ± 0.01, n ¼ 7, P > 0.05) or the S897A (0.10 ± 0.02, n ¼ 7, P > 0.05) substitution. These results show that specifically GluN1 S896, which is a PKC phosphorylation site, can control the level of GluN1/GluN3A steady-state current, which may in turn dictate their tonic levels in vivo.
Discussion
NMDA receptors play myriad roles in the development and function of the mammalian CNS and have been implicated in neurologic and psychiatric dysfunctions. In part, this diversity reflects differential expression of receptor subtypes with distinct molecular composition and functional properties. Here we describe biophysical and pharmacologic properties of four recombinant GluN1-a/GluN3A receptor subtypes, which differ in the sequence of the intracellular tail of the GluN1-a subunit.
All four GluN1-a/GluN3A subtypes tested produced deeply desensitizing macroscopic currents in response to prolonged glycine applications, with decay time courses in the 0.2e0.4 s range. These kinetics are substantially faster than those reported for glutamatergic GluN1/GluN2 receptors, which desensitize with a time course of~1e2 s but still two orders of magnitude slower than the desensitization kinetics of non-NMDA receptors (Traynelis et al., 2010) . Given that GluN1/GluN3A receptors are unlikely to experience brief pulses of glycine, but rather sustained ambient glycine levels, the level of residual or steady-state current is a more physiologically-relevant parameter. The steady-state current will vary with the level of protein expression, and with each receptor's steady-state open probability.
Here, we took advantage of a heterologous expression system to investigate molecularly defined subtypes of GluN1/GluN3A receptors; therefore, our measurements do not inform whether in neurons or glial cells, receptors with distinct GluN1 intracellular tails may have different levels of expression or surface trafficking. In HEK293 cells, we observed higher expression of receptors containing GluN1-3a and GluN1-4a, but whether these results apply to native preparations is unclear. Further, the absolute open probability of GluN1/GluN3A receptors remains unknown. However, we observed distinct differences in the extent of macroscopic desensitization for the four isoforms investigated, which is a strong indication that the C-terminal tail of the GluN1 subunit controls the level of steady-state current, a biologically salient parameter of the GluN1/GluN3A response. Relative to their respective peak current levels (I pk ), receptors containing GluN1-2 or GluN1-3 subunits produced 4-fold more steady-state current (I ss ) than receptors containing GluN1-1 or GluN1-4 subunits (~8% vs~2% residual current, respectively). Such changes will likely decrease the resting membrane potential, and possibly increase excitability in cells that express receptors with larger steady-state currents. On the other hand, given that persistent depolarization can lead to decreased cellular excitability due to inactivation of voltage-gated sodium channels (Catterall, 2000) , it is possible that persistent GluN1/GluN3A activity may serve to decrease excitability. Regardless of directionality, our new results suggest that regulated splicing of the GluN1 subunit may control cellular excitability in cells expressing GluN1/GluN3A channels. The mechanism by which the intracellular domains of GluN1 subunits affect channel activity is unknown; however, our mutagenesis results are consistent with the view that perturbations in the C-terminal domain can alter receptor gating.
We compared glycinergic responses from receptors with targeted phosphomimic and phosphodeficient mutations in the Cterminal tail of the GluN1-3 subunit, and found that changes in the phosphorylation status of PKA/PKC targeted residues, but not of the putative tyrosine kinase residues, can modify the fraction of residual current. This result is important on several levels. First, it demonstrates that receptor desensitization is sensitive to the phosphorylation status of residues known to be under kinase regulation in vivo (Traynelis et al., 2010; Zukin and Bennett, 1995; Tingley et al., 1997; Chen and Roche, 2007) and that this modulation is site specific. Second, it suggests that phosphorylation may be a physiologic mechanism of controlling residual current from GluN1/GluN3A receptors containing GluN1 variants 1 or 3, but not 2 or 4. Alternatively, differential splicing may serve to add or remove kinase-dependent sensitivity for glycinergic excitation.
Notably, relative to phosphorylation deficient mutations, phosphomimic mutations decreased the relative residual current. This is in contrast to glutamatergic NMDA receptors, for which as a general rule phosphorylation increases receptor activity (Aman et al., 2014; Chen and Roche, 2007) . Our novel observation is consistent with an overall trend where modulators effective at both GluN1/GluN2 and GluN1/GluN3 receptors, such as protons, zinc, and phosphorylation, have opposing effects on the currents generated by these receptors (Cummings and Popescu, 2016; Madry et al., 2008; Paoletti et al., 1997; Traynelis and Cull-Candy, 1990 ).
All receptors we examined were sensitive to potentiation by zinc and protons, but showed different levels of modulation. Receptors with highest levels of residual current (less desensitization) also showed least potentiation by protons, consistent with the hypothesis that protons potentiate GluN1/GluN3A currents by reducing desensitization (Cummings and Popescu, 2016) . In contrast, the levels of potentiation by zinc showed no correlation with desensitization levels, or with the pattern of proton potentiation, consistent with the hypothesis that zinc and protons affect GluN1/GluN3A activity through separate mechanisms (Cummings and Popescu, 2016; Madry et al., 2008) .
Last, all receptors we tested had currents with similar reversal potentials, relative calcium to sodium permeability, and voltagedependent Ca 2þ block. These results indicate that the permeation pathway is insensitive to perturbations in the intracellular residues of the GluN1 subunit. These results also differentiate glycinergic NMDA receptors from their more intensely investigated glutamatergic relatives, for which perturbations in the GluN1 C-terminal domain, whether by splicing or phosphorylation, modify channel permeation properties (Aman et al., 2014; Logan et al., 1999) . Throughout this study, we recorded GluN1/GluN3A activity in slightly acidic conditions (pH 6.8) where they exhibit maximal activity (Cummings and Popescu, 2016) . Although this was for practical reasons, results have bearing on pathologic situations where the pH of the interstitial fluid decreases, such as following acute ischemic or traumatic insults, or chronically, as in amyotrophic lateral sclerosis and schizophrenia (Lipska et al., 2006; Prabakaran et al., 2004; Torrey et al., 2005; Dodge et al., 2013) .
In summary, our results show that perturbations in the C-terminal tail of the GluN1 subunit control the level of steady-state GluN1/GluN3A current by changing receptor gating. This information is valuable in several ways. First, because at this time, the exact molecular composition of NMDA receptors expressed at specific locations in the mammalian CNS is unknown, information about subtype-specific kinetic and pharmacological properties can help evaluate which receptor subtypes contribute to the observed electrical response in native preparations during physiologic or pathologic conditions. Second, because the expression of receptors that differ in their GluN1 intracellular sequence is naturally controlled, our results reveal which properties of the native response are sensitive to this regulation. Last, the ability of GluN1 C-terminal splicing to control the glycinergic current may have important functional consequences under pathological conditions that influence the relative abundance of GluN1 splice, as for example in schizophrenia, (Vrajova et al., 2010) . Together with emerging knowledge about the complement of subunits expressed in vivo, the new functional data we report here will help to delineate the roles played by glycinergic excitatory NMDA receptors in the health and disease of the CNS.
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